Browsing: Homepage Slider
Results of a Phase I study have suggested multisite stereotactic body radiotherapy prior to immunotherapy treatment may improve patient outcomes.
To mark World Cancer Day we are highlighting the most significant advancements in modern oncology to investigate how the field has advanced and what hurdles still need to be overcome.
Merck has extended its all-important lung-cancer lead, after combination Phase III trial demonstrates that Keytruda extends lung cancer survival.
Right now, doctors can’t tell whether women with DCIS will go on to develop breast cancer. This means that, unfortunately, some women with DCIS undergo unnecessary treatment. Find out how Jelle and his team are looking to change this.
Would you like to discover exclusive content from the hottest topics in oncology? Editor, Jade Parker, highlights Oncology Centrals top content in this report.
In this opinion piece from our Editor, Jade Parker, you can discover the top 5 breast cancer advancements of 2017.